The latter update is the state-of-the-art mechanistic model for T2DM and has been leveraged in recent investigations on, for example, the efficiency of smart algorithms for insulin therapy [19] and the impact of insulin therapy adherence on glucose control [20]. Here, INS is linked to type 2 diabetes mellitus.